» Articles » PMID: 38607025

Stem Cells Collection and Mobilization in Adult Autologous/Allogeneic Transplantation: Critical Points and Future Challenges

Abstract

Achieving successful hematopoietic stem cell transplantation (HSCT) relies on two fundamental pillars: effective mobilization and efficient collection through apheresis to attain the optimal graft dose. These cornerstones pave the way for enhanced patient outcomes. The primary challenges encountered by the clinical unit and collection facility within a transplant program encompass augmenting mobilization efficiency to optimize the harvest of target cell populations, implementing robust monitoring and predictive strategies for mobilization, streamlining the apheresis procedure to minimize collection duration while ensuring adequate yield, prioritizing patient comfort by reducing the overall collection time, guaranteeing the quality and purity of stem cell products to optimize graft function and transplant success, and facilitating seamless coordination between diverse entities involved in the HSCT process. In this review, we aim to address key questions and provide insights into the critical aspects of mobilizing and collecting hematopoietic stem cells for transplantation purposes.

Citing Articles

Repurposing the prostaglandin analogue treprostinil and the calcium-sensing receptor modulator cinacalcet to revive cord blood as an alternate source of hematopoietic stem and progenitor cells for transplantation.

Prchal-Murphy M, Zehenter J, Fischer M, Pirabe A, Themanns M, Afrashteh B Front Pharmacol. 2025; 15():1444311.

PMID: 39850556 PMC: 11755040. DOI: 10.3389/fphar.2024.1444311.


Population Pharmacokinetic-Pharmacodynamic Modeling of Granulocyte Colony-Stimulating Factor to Optimize Dosing and Timing for CD34 Cell Harvesting.

Jiang X, Cha J, Jin B, Kim C, Chae D Clin Transl Sci. 2025; 18(1):e70121.

PMID: 39748466 PMC: 11695272. DOI: 10.1111/cts.70121.


Predicting apheresis yield and factors affecting peripheral blood stem cell harvesting using a machine learning model.

Qi J, Chen Y, Jin X, Wang R, Wang N, Yan J J Int Med Res. 2024; 52(12):3000605241305360.

PMID: 39719078 PMC: 11683808. DOI: 10.1177/03000605241305360.

References
1.
Lanza F, Marchetti M, Zannetti B . Overview on novel strategies and current guidelines for hematopoietic stem cell mobilisation and collection. Transfus Apher Sci. 2023; 62(6):103830. DOI: 10.1016/j.transci.2023.103830. View

2.
Trebeden-Negre H, Rosenzwajg M, Tanguy M, Lefrere F, Azar N, Heshmati F . Delayed recovery after autologous peripheral hematopoietic cell transplantation: potential effect of a high number of total nucleated cells in the graft. Transfusion. 2010; 50(12):2649-59. DOI: 10.1111/j.1537-2995.2010.02746.x. View

3.
Shi P, Miller L, Isola L . Prospective study of mobilization kinetics up to 18 hours after late-afternoon dosing of plerixafor. Transfusion. 2013; 54(5):1263-8. PMC: 3989464. DOI: 10.1111/trf.12459. View

4.
Liu W, Li Y, Wang Q, Su H, Ding K, Shuang Y . YF-H-2015005, a CXCR4 Antagonist, for the Mobilization of Hematopoietic Stem Cells in Non-Hodgkin Lymphoma Patients: A Randomized, Controlled, Phase 3 Clinical Trial. Front Med (Lausanne). 2021; 8:609116. PMC: 7884449. DOI: 10.3389/fmed.2021.609116. View

5.
Vacca M, Perseghin P, Accorsi P, Pierelli L . Central venous catheter insertion in peripheral blood hematopoietic stem cell sibling donors: the SIdEM (Italian Society of Hemapheresis and Cell Manipulation) point of view. Transfus Apher Sci. 2014; 50(2):200-6. DOI: 10.1016/j.transci.2014.02.001. View